New member | MAD-UP
MAD-UP specializes in the development of technological solutions for the health care of musculoskeletal disorders. Its intelligent dynamic compression solution... View Article
GlioCure announces that it has been granted patent protection of its drug candidate GC01 in India
GlioCure SAS, a biotechnology company specialised in neuro-oncology, announced that it has been granted an Indian patent for its drug... View Article
OSE Immunotherapeutics Announces Enrolment of First Patient with Ulcerative Colitis in Phase 2 Trial Testing Anti-IL-7 Receptor Antagonist OSE-127/S95011
OSE Immunotherapeutics today announced enrolment of the first patient in its Phase 2 clinical trial evaluating the benefits of anti-IL-7... View Article
OSE Immunotherapeutics Receives €5.2 M in Public Funding for the Clinical Development of CoVepiT, its Second Generation COVID-19 Vaccine
• CoVepiT demonstrated generation of sentinel memory T cells with long-term protective effect against COVID-19 in preclinical and human ex... View Article
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today announced the initiation of... View Article
New member | Substra Foundation
Substra Foundation is an independent nonprofit organization dedicated to fostering the development of trustworthy data science ecosystems. It promotes, protects... View Article
BHealthCare raises € 1.5 M to finalise development of its robotic blood sampling platform, HEIVA™
BHealthCare, a MedTech specialising in the development of next-generation robotic solutions to provide more reliable peripheral vascular access, has announced... View Article
The “France Relance” stimulus package: the Healthcare Clusters network proposes three options to guarantee French healthcare sovereignty
Improve access to equity by launching novel specialised investment funds Support research and innovation by issuing calls for projects with... View Article
A Nanofitins production unit: a project run by Affilogic, winner of the industrial relocation plan
Affilogic, a company specialising in the discovery and development of Nanofitins® for biotherapeutic applications, is one of the 31 projects... View Article
Atlanpole Biotherapies | Customized services
Broadly speaking, cluster members are offered customized services that open up a path to European funding aimed at boosting innovation... View Article